Table 3.

Comparison of TTNT at 4 years according to risk factors at diagnosis

Risk factorsnTTNT at 4 years, %P valuea 
All 313 61  
Age, y   .008 
<65 143 70  
≥65 170 53  
Ibrutinib use   <.0001 
First or second line 104 68  
Third or further lines 209 48  
IGHV status   .14 
Mutated 31 41  
Unmutated 71 70  
Del(17p) and/or TP53 mutation   .002 
Absent 152 68  
Present 42 43  
Risk factorsnTTNT at 4 years, %P valuea 
All 313 61  
Age, y   .008 
<65 143 70  
≥65 170 53  
Ibrutinib use   <.0001 
First or second line 104 68  
Third or further lines 209 48  
IGHV status   .14 
Mutated 31 41  
Unmutated 71 70  
Del(17p) and/or TP53 mutation   .002 
Absent 152 68  
Present 42 43  
a

P value ≤ .05 is boldfaced.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal